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Insulin resistance and β cell dysfunction are key features of the pathophysiology of type 2 diabetes mellitus (T2DM), 
the prevalence of which is rapidly increasing. Central obesity 
and low physical activity, in turn, are main underlying causes 
of insulin resistance. We1 and others2 have recently advanced 
the hypothesis that microvascular dysfunction, by impairing 
the timely access of glucose and insulin to their target tissues, 
is an additional cause of insulin resistance. In addition, micro-
vascular dysfunction may function as an intermediate step 
linking central obesity, low physical activity, and chronic low-
grade inflammation to insulin resistance3 (Figure 1).
There is substantial evidence in support of this hypothesis. 
For example, it has been demonstrated that insulin can redirect 
blood flow in skeletal muscle from nonnutritive capillaries to 
nutritive capillaries and thereby increase insulin-mediated 
glucose uptake without increasing total blood flow.4 This pro-
cess, so-called capillary recruitment, is impaired in insulin-
resistant individuals.5,6 In addition, experimental studies have 
demonstrated impairments in glucose disposal after block-
ing insulin-mediated capillary recruitment,7 suggesting that 
microvascular dysfunction directly affects insulin-mediated 
glucose disposal. It is not clear, however, whether there is 
consistent prospective evidence to support this hypothesis, 
although, since the early 2000s, a growing number of prospec-
tive studies have investigated the association between various 
estimates of microvascular dysfunction and incident T2DM 
and impaired fasting glucose (IFG).
In view of these considerations, we conducted a systematic 
review and meta-analysis of these prospective studies to 
investigate whether microvascular dysfunction is associated 
with incident T2DM and IFG in population-based settings
Materials and Methods
Search Strategy
We conducted a search in Medline and Embase for studies published 
from inception (1977) to October 2011. We considered 4 types of 
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Objective—Recent data support the hypothesis that microvascular dysfunction may be a potential mechanism in the 
development of insulin resistance. We examined the association of microvascular dysfunction with incident type 2 
diabetes mellitus (T2DM) and impaired glucose metabolism by reviewing the literature and conducting a meta-analysis 
of longitudinal studies on this topic.
Methods and Results—We searched Medline and Embase for articles published up to October 2011. Prospective cohort 
studies that focused on microvascular measurements in participants free of T2DM at baseline were included. Pooled relative 
risks were calculated using random effects models. Thirteen studies met the inclusion criteria for this meta-analysis. These 
studies focused on T2DM or impaired fasting glucose, not on impaired glucose tolerance. The pooled relative risks for 
incident T2DM (3846 cases) was 1.25 (95% confidence interval, 1.15; 1.36) per 1 SD greater microvascular dysfunction 
when all estimates of microvascular dysfunction were combined. In analyses of single estimates of microvascular 
dysfunction, the pooled relative risks for incident T2DM was 1.49 (1.36; 1.64) per 1 SD higher plasma soluble E-selectin 
levels; 1.21(1.11; 1.31) per 1 SD higher plasma soluble intercellular adhesion molecule-1 levels; 1.48 (1.03; 2.12) per 
1 SD lower response to acetylcholine-mediated peripheral vascular reactivity; 1.18 (1.08; 1.29) per 1 SD lower retinal 
arteriole-to-venule ratio; and 1.43 (1.33; 1.54) per 1 logarithmically transformed unit higher albumin-to-creatinine ratio. 
In addition, the pooled relative risks for incident impaired fasting glucose (409 cases) was 1.15 (1.01–1.31) per 1 SD 
greater retinal venular diameters.
Conclusion—These data indicate that various estimates of microvascular dysfunction were associated with incident 
T2DM and, possibly, impaired fasting glucose, suggesting a role for the microcirculation in the pathogenesis of 
T2DM. (Arterioscler Thromb Vasc Biol. 2012;32:3082-3094.)
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estimates of microvascular function. First, we included plasma mark-
ers of endothelial dysfunction, defined as markers that are synthesized 
to an important extent by the endothelium (regardless of whether they 
are also synthesized by other cell types), including soluble E-selectin 
(sE-selectin), soluble intercellular adhesion molecule-1 (sICAM-
1), soluble vascular cell adhesion molecule-1 (sVCAM-1), and von 
Willebrand factor (vWF).8 Higher concentrations of these markers 
are associated with cardiovascular disease9 and are thought to be 
derived mainly from microcirculatory endothelium,10 which makes it 
plausible that higher concentrations of these markers reflect greater 
microvascular endothelial dysfunction. Second, we included assess-
ment of skin and muscle microcirculation (by capillaroscopy and 
laser-Doppler fluxmetry, and plethysmography, respectively), with 
lower responses reflecting microcirculatory dysfunction. Third, we 
included retinal diameters, as evaluated by retinal photography. We 
defined greater venular diameters and both lower arteriolar diameters 
and lower arteriole-to-venule ratios (AVRs) as markers of microvas-
cular dysfunction, because greater retinal venular diameters are asso-
ciated with atherosclerosis, inflammation, and cholesterol levels, and 
both lower AVRs and generalized arteriolar narrowing are associated 
with incident cardiovascular disease.11 Finally, we included microal-
buminuria, which is thought to reflect a generalized increase in endo-
thelial permeability.8 Therefore, higher values of urinary albumin 
excretion (UAE; expressed as albumin–to–creatinine ratio [ACR] or 
as UAE per time) are thought to reflect greater microvascular endo-
thelial dysfunction.
To identify the studies of interest, we used the following terms: 
plasma markers of endothelial dysfunction (sE-selectin, sICAM-1, 
sVCAM-1, vWF); peripheral vascular reactivity (forearm blood flow, 
plethysmography, acetylcholine, sodium nitroprusside, L-NMMA); 
skin microvascular endothelium-dependent or -independent reactivity 
(iontophoresis, intracutaneous injection, acetylcholine, sodium nitro-
prusside, L-NMMA); capillary density (capillary density, capillary 
recruitment, capillaroscopy, capillaries); retinal diameters (retinal 
vessels, arteriovenous ratio, AVR, venular diameter, arteriolar diam-
eter, retinal arteriolar diameter); and microalbuminuria (microalbu-
minuria, macroalbuminuria, albuminuria, ACR, UAE). These search 
strategies were combined with the terms (risk of) diabetes, glucose 
tolerance, cohort, follow-up, longitudinal. The search was limited to 
studies within humans and to studies written in English. Finally, we 
examined the reference lists of the selected papers to find other rel-
evant articles.
Selection Criteria and Data Extraction
Three authors (D.M.J.M., A.J.H.M.H., and M.T.S.) independently 
selected articles. Prospective cohort studies that measured microvas-
cular function in participants free of T2DM at baseline were included. 
First, titles and abstracts of the retrieved studies were scanned and 
excluded if they were irrelevant. After title and abstract selection, 
the full text of the included articles was read to identify whether the 
studies met the prespecified inclusion criteria. After the selection 
procedure, the following data were extracted: characteristics of the 
study population, number of participants without T2DM at baseline, 
incident cases of T2DM or IFG, mean follow-up, definition of T2DM 
or IFG, the crude and adjusted odds ratios (OR), relative risks (RR) 
or hazard ratios (HR) with 95%CI, confounding variables included in 
the analyses, and the incidence and cumulative incidence of T2DM 
and IFG. When these data were missing, the principal investigator 
of the selected study was contacted for further information. If the 
investigator could not provide the requested information or did not 
respond, the available data were used.
Statistical Analysis
Incidences and Cumulative Incidences
When incidence data were not presented in the original article, 
cases per 1000 person-years and cumulative incidences were cal-
culated. We used the following formulas: cases per 1000 person-
years = ([T2DM or IFG cases/person-years]×1000), person-years = 
(participants×follow-up time), and cumulative incidence = ([T2DM 
or IFG cases/controls×100%). If the person-years were not specified 
in the article, T2DM or IFG cases were set at half of the duration of 
the follow-up.
Statistical Analysis for the Meta-Analysis
Meta-analysis was performed by use of RevMan5,12 using the generic 
inverse variance method with a random effects model. One SD dif-
ference of the independent variable in the fully adjusted models was 
used to estimate the pooled RRs and 95%CI. The pooled effect sizes 
were estimated by calculating the logarithm of the RR and the stan-
dard error. In this analysis, larger studies with smaller standard errors 
have a greater weight than smaller studies with larger standard errors. 
A forest plot was made to show the pooled RRs and 95%CIs. We 
assumed that the populations in the different studies share the same 
underlying distribution of the microvascular markers. Therefore, dif-
ferent SDs of the microvascular markers are likely to be the result 
of measurements errors, and risk per 1SD can be compared without 
conversion.13 Heterogeneity was assessed visually by forest plots, 
by means of Cochran’s Q test, of which the null hypothesis assumes 
homogeneity,14 and by I2 statistics, which indicates the percentage of 
variability across trials that is explained by heterogeneity rather than 
chance.15
Because of the highly skewed distribution, the continuous variables 
ACR and UAE were logarithmically transformed, and results on the 
association of microalbuminuria with incident T2DM are expressed 
per logarithmically transformed unit higher ACR or UAE. All loga-
rithmic transformations were to the base e.
Results
Study Selection and Characteristics
The literature search resulted in 2722 articles (Figure I in 
the online-only Data Supplement). After title, abstract, and 
Figure 1. Hypothesis which states that microvascular dysfunc-
tion may function as an intermediate step linking central obesity 
and low physical activity to insulin resistance (and, downstream, 
type 2 diabetes mellitus) and hypertension (adapted from Jonk3). 
ACE indicates angiotensin converting enzyme; ARB, angiotensin 
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full text selection, 23 articles were found that investigated 
the association of plasma markers of endothelial dysfunction 
(n=11), peripheral vascular reactivity (n=1), retinal diameters 
(n=5), and microalbuminuria (n=6), respectively, with incident 
T2DM or IFG. These studies focused on T2DM or IFG, not on 
impaired glucose tolerance (IGM). We did not find any articles 
that prospectively investigated the association of skin micro-
vascular endothelium-dependent or -independent reactivity and 
capillary density or recruitment with incident IGM or T2DM.
Table 1 shows the characteristics of the selected studies. All 
articles were published in English after 1994. We found 15 
prospective population-based cohort studies,16–30 3 prospective 
nested case-control studies,31–33 and 5 prospective case–cohort 
studies.34–38 The studies examined mainly white participants 
from Europe, the United States, and Australia. As expected, 
subjects who developed T2DM during follow-up were slightly 
older and had a higher body mass index (BMI) at baseline. 
In addition, 10.2% to 70.2% of the subjects had hypertension 
at baseline and 9.3% to 72.6% of the subjects were current 
smokers. The follow-up time of the studies ranged from 2.6 
to 12 years. The included studies used different measures 
to diagnose T2DM and IFG, mainly based on the American 
Diabetes Association (1997 and 2003) and World Health 
Organization (1985 and 2006) criteria. Most studies compared 
incident T2DM with a combined sample of non-T2DM and 
incident IFG. Two studies20,21 compared incident T2DM and 
IFG with non-T2DM.
Plasma samples of sE-selectin, sVCAM-1, sICAM-1, and 
vWF were analyzed by use of ELISAs. Peripheral vascular 
reactivity was assessed by a dose-response curve to intra-
arterial infusion of acetylcholine (7.5, 15, and 30 μg·mL−1·
min−1).25 Retinal diameters were evaluated offline by the use 
of fundus photos (Retinal Analysis; Optimate, Madison, WI). 
ACR or UAE were calculated to determine microalbuminuria. 
Five studies assessed microalbuminuria in a morning fasting 
spot urine sample,18,19,23,27,33 whereas 1 study assessed microal-
buminuria by use of two 24-hour urine collections.16
Microvascular Dysfunction and Risk of T2DM
Eleven studies17,22,26,28,31,32,34–38 investigated the association of 
microvascular dysfunction as measured by plasma mark-
ers of endothelial dysfunction and incident T2DM. Table I in 
the online-only Data Supplement shows a higher incidence of 
T2DM at higher levels of sE-selectin, sICAM-1, and vWF at 
baseline. Only the Western New York Study37 showed a lower 
incidence of T2DM at a higher level of sICAM-1 at baseline. 
Table 2 illustrates the associations of plasma markers of endothe-
lial dysfunction with incident T2DM, comparing the upper with 
the lower tertile/quartile. Plasma markers of sE-selectin, sICAM-
1, sVCAM-1, and vWF were positively and significantly asso-
ciated with incident T2DM. After adjustment for confounders, 
including age, sex, race, and body composition, sE-selectin and 
sICAM-1 remained associated with incident T2DM, with RRs 
ranging from 1.34 (95%CI, 0.91; 1.99) to 4.61 (2.85; 7.46) and 
from 1.03 (0.64; 1.67) to 1.84 (1.26; 2.69) respectively.
One study investigated the association of peripheral vascular 
reactivity with incident T2DM.25 An attenuated endothelium-
dependent vasoreactivity response was significantly associated 
with incident T2DM; the association remained present after 
adjustment for age, sex, BMI, smoking, systolic blood pres-
sure, total cholesterol, fasting glucose, fasting insulin, homeo-
stasis model of assessment-insulin resistance, and C-reactive 
protein (HR 1.30 [1.01; 1.64]).
Five studies assessed the relationship between retinal diam-
eters and incident T2DM.20,21,24,29,30 Table I in the online-only 
Data Supplement shows a higher incidence of T2DM with 
smaller baseline arteriolar diameters and AVR. In contrast, 
venular diameters were not significantly associated with the 
incidence of T2DM. Table 2 illustrates that lower AVRs were 
significantly associated with incident T2DM in all 3 stud-
ies,20,29,30 with RRs ranging from 1.53 (1.03; 2.27) to 1.92 
(1.10; 3.36). No significant associations were found between 
either venular or arteriolar diameters and the development of 
T2DM, except in the AusDiab Study,24 which showed a sig-
nificant association for arteriolar diameters (OR, 2.21 [1.02; 
4.80]). All studies adjusted for age, sex, smoking, systolic 
blood pressure, and fasting plasma glucose levels. The stud-
ies additionally adjusted for ethnicity, study center, BMI, waist 
circumference, physical activity, alcohol consumption, dia-
stolic blood pressure, hypertension, family history of diabetes 
mellitus, total cholesterol, high density lipoprotein cholesterol, 
fasting insulin levels, IFG/impaired glucose tolerance, cho-
lesterol-lowering medication, follow-up time, HbA1c, carotid 
plaque score, retinopathy, and ACR, although not all studies 
used the same variables in the fully adjusted models (Table 2).
Six studies investigated the association between microal-
buminuria with incident T2DM.16,18,19,23,27,33 The incidence of 
T2DM was higher at higher levels of UAE and ACR, or in 
presence of microalbuminuria at baseline (Table I in the online-
only Data Supplement). In addition, all 6 studies showed that 
the presence of microalbuminuria was significantly associated 
with incident T2DM. After adjustment for potential confound-
ers, the associations remained present in 5 studies, with RRs 
ranging from 1.40 (0.82; 2.39) to 2.36 (1.01; 5.50), although 
studies adjusted for different variables in the analyses (Table 2).
Meta-Analysis 
With regard to plasma markers, 2 studies34,36 presented their 
results in figures and therefore did not report exact RR. Five 
studies presented their data in units that we could not trans-
form into SDs (either tertiles28,35,37,38 or quintiles.31) The remain-
ing 4 studies22,26,32,36 were included in the meta-analysis. With 
regard to peripheral vascular reactivity, only 1 study25 was 
available (Figure 2). With regard to retinal diameters, all 5 
studies20,21,24,29,30 were included in the meta-analysis and are pre-
sented in Figure 2. For microalbuminuria, 3 studies presented 
UAE16 and ACR18,33 as a continuous variable. These studies are 
presented in Figure 2.
Figure 2 shows that 1 SD greater microvascular dysfunc-
tion was associated with a 25% (15; 36%) higher incidence 
of T2DM. In addition, 1 SD higher levels of plasma markers 
of endothelial function were associated with a 21% (5; 39%) 
higher incidence of T2DM. In analyses of single estimates 
of microvascular dysfunction (Figure 2), 1 SD higher levels 
of sE-selectin and sICAM-1 were significantly associated 
with a 49% (36; 64%) and 21% (11; 31%) higher incidence 
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(15% [−9; 44%]) were not significantly associated with inci-
dent T2DM. One SD lower vasodilatory response to acetyl-
choline was associated with a 48% (3; 102%) higher incidence 
of T2DM. In addition, 1 SD lower AVR was associated with 
an 18% (8; 29%) higher incidence of T2DM. Greater venular 
diameters and 1 SD lower arteriolar diameters were positively, 
but not significantly, associated with a 6% (−3; 15%) and 8% 
(−4; 22%) higher incidence of T2DM, respectively. Finally, 
Figure 2. Forest plot showing the relative risk (RR) and 95%CI for each study, and the pooled RR and 95%CI for risk of type 2 diabetes 
mellitus. sE-selectin indicates soluble E-selectin; sICAM-1, soluble intercellular adhesion molecule-1; sVCAM-1, soluble vascular cell 
adhesion molecule-1; vWF, von Willebrand factor. 
Study SD
Plasma markers of endothelial dysfunction
1SD higher levels of sE-selectin
Longitudinal health study in Pima indians 36 1.34 (0.91-1.99) NA
The women's health initiative observational study 32 1.50 (1.36-1.65) 20.4 ng/ml
1.49 (1.36-1.64)
Test for overall effect: Z = 8.45 (P < 0.001)
1SD higher levels of sICAM-1
The prospective study of pravastatin in the elderly at risk 26 1.22 (1.08-1.38) 1.4 ng/ml*
The women's health initiative observational study 32 1.20 (1.06-1.34) 89.3 ng/ml
1.21 (1.11-1.31)
Test for overall effect: Z = 4.53 (P < 0.001)
1SD higher levels of sVCAM-1
The women's health initiative observational study 32 1.02 (0.91-1.16) 245 ng/ml
Test for overall effect: Z = 0.30 (P = 0.76)
1SD higher levels of vWF
The Framingham offspring study 17 1.33 (1.03-1.73) 65% control
Longitudinal health study in Pima indians 36 0.73 (0.46-1.16) NA
1.15 (0.91-1.44)
Test for overall effect: Z = 1.19 (P = 0.24)
1SD higher levels of plasma markers of endothelial function 1.21 (1.05-1.39)
Heterogeneity: Chi² = 29.76, df = 6 (P < 0.001); I² = 80%
Test for overall effect: Z = 2.69 (P = 0.007)
Peripheral vascular reactivity
1SD lower vasodilatory response to acetylcholine
Perticone, 2008 25 1.48 (1.03-2.12) 149%
Test for overall effect: Z = 2.14 (P = 0.03)
Retinal diameters
Risk ratio (95% CI)
1SD greater venular diameter
The Rotterdam study 20 1.08 (0.86-1.36) 19.9 µm
The blue mountains eye study 21 1.06 (0.87-1.29) 20.0 µm
The AusDiab study 24 1.30 (1.00-1.68) 22.2 µm
The beaver dam eye study 30 1.01 (0.91-1.12) 22.8 µm
1.06 (0.97-1.15)
Test for overall effect: Z = 1.26 (P = 0.21)
1SD lower arteriolar diameter
The Rotterdam study 20 1.02 (0.81-1.28) 14.1 µm
The blue mountains eye study 21 0.93 (0.77-1.13) 20.0 µm
The AusDiab study 24 1.33 (1.03-1.72) 23.5 µm
The beaver dam eye study 30 1.11 (1.00-1.23) 17.1 µm
1.08 (0.96-1.22)
Test for overall effect: Z = 1.25 (P = 0.21)
1SD lower arteriole-to-venule ratio 
The Rotterdam study 20 1.09 (0.87-1.36) 0.06 units
The atherosclerosis risk in communities study 29 1.26 (1.09-1.46) 0.08 units
The beaver dam eye study 30 1.16 (1.02-1.32) 0.07 units
1.18 (1.08-1.29)
Test for overall effect: Z = 3.71 (P < 0.001)
Microalbuminuria
1 logarithmic transformed unit higher albumin-to-creatinine ratio
The prevention of renal and vascular end stage disease study 16 1.53 (1.25-1.88) NA
Wang, 2006 33 1.71 (1.13-2.59) NA
Diabetes Mellitus prevention program 18 1.41 (1.30-1.53) NA
1.43 (1.33-1.54)
Test for overall effect: Z = 9.58 (P < 0.001)
1SD greater microvascular dysfunction 1.25 (1.15-1.36)
Heterogeneity: Chi² = 56.15, df = 18 (P < 0.001); I² = 77%
Test for overall effect: Z = 5.12 (P < 0.001)
* Geometric SD
NA not applicable or not described in article
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1 logarithmically transformed unit higher UAE or ACR was 
associated with a 43% (33; 54%) higher incidence of T2DM.
Microvascular Dysfunction and Risk of IFG
Two studies, the Rotterdam Study20 and the Blue Mountains 
Eye Study,21 investigated the relationship between micro-
vascular dysfunction as measured by retinal diameters and 
incident IFG. These studies did not specify cumulative inci-
dences per tertile/quartile (Table I in the online-only Data 
Supplement). Table 2 illustrates the associations of retinal 
diameters with incident IFG, comparing the upper to the 
lower tertile/quartile. The Rotterdam Study20 showed a sig-
nificant association between both larger venular diameters 
(OR, 1.46 [1.02; 2.08]) and smaller AVR (OR, 1.93 [1.35; 
2.77]), and the development of IFG. The Blue Mountains 
Eye Study21 showed a positive association between larger 
venular diameters (OR, 1.16 [0.91; 1.47]) and the develop-
ment of IFG. Both studies adjusted for age, sex, BMI, smok-
ing, systolic blood pressure, and high density lipoprotein 
cholesterol. The Rotterdam Study20 additionally adjusted 
for diastolic blood pressure, total cholesterol, C-reactive 
protein, follow-up time, and carotid plaque score. In con-
trast, the Blue Mountains Eye Study21 additionally adjusted 
for alcohol consumption, family history of diabetes melli-
tus, fasting plasma glucose levels, and cholesterol-lowering 
medication.
Meta-Analysis 
One SD greater venular diameters were associated with a 15% 
(1; 31%) higher incidence of IFG (Figure 3). Arteriolar diam-
eter was not associated with incident IFG. The Rotterdam 
Study20 also showed that 1SD lower AVR was associated with 
a 14% (−2; 32%) higher incidence of IFG.
Discussion
This study represents the first systematic overview regarding 
microvascular dysfunction as a risk factor for incident T2DM 
and IFG. This review had 2 main findings. First, several mark-
ers of microvascular dysfunction, including plasma markers, 
peripheral vascular reactivity, AVR, and microalbuminuria 
were associated with incident T2DM. Second, greater venular 
diameters were associated with incident IFG. These findings 
are consistent with the hypothesis that microvascular dysfunc-
tion is causally linked with T2DM.
Our meta-analysis confirms that microvascular dysfunc-
tion was associated with a 10% to 49% higher incidence of 
T2DM and an 8% to 15% higher incidence of IFG. Several 
mechanisms, not mutually exclusive, may explain the asso-
ciation between microvascular dysfunction with both T2DM 
and IFG. First, one underlying mechanism is likely to involve 
the concept that insulin normally can redirect blood flow in 
skeletal muscle from nonnutritive capillaries to nutritive cap-
illaries and thereby increase insulin-mediated glucose uptake 
without increasing total blood flow,39 and that these processes 
are impaired in states of microvascular dysfunction, such as 
obesity, low physical activity, and chronic low-grade inflam-
mation.3 Notably, specific inhibition of insulin-mediated 
microvascular effects has been shown to cause a 30% to 40% 
reduction in glucose disposal.7 Second, it has been suggested 
that (pancreatic) microvascular endothelial dysfunction causes 
apoptosis of β cells in the pancreas.40 This process decreases 
insulin secretory capacity and thus may lead to hyperglyce-
mia, which, in addition, can further impair endothelial (micro-
vascular) function, thus leading to a vicious cycle that may 
play a crucial role in the development of T2DM.40
Our analysis demonstrated consistent positive associations 
across all markers of microvascular endothelial dysfunction 
used. An important assumption in this reasoning is that these 
markers are valid indicators of microvascular endothelial dys-
function.41 The endothelium is a key regulator of permeability, 
vascular tone, and hemostasis. Thus, endothelial dysfunction 
can be manifested as increased microvascular permeability and 
impaired balance between vasodilatation and vasoconstric-
tion, as well as between thrombotic and antithrombotic prop-
erties.8 Likewise, plasma markers of endothelial dysfunction, 
peripheral vascular reactivity, retinal diameters, and microal-
buminuria may reflect different manifestations of these dis-
turbances of the microvascular endothelium. First, E-selectin, 
ICAM-1, and VCAM-1 are thought to increase endothelial 




1SD greater venular diameter
The Rotterdam study 20 1.15 (0.99-1.34) 19.9 µm
The Blue Mountains Eye study 21 1.16 (0.91-1.47) 20.0 µm
1.15 (1.01-1.31)
Test for overall effect: Z = 2.19 (P = 0.03)
1SD lower arteriolar diameter
The Rotterdam study 20 
The Blue Mountains Eye study 21
0.99 (0.86-1.14) 14.1 µm
0.98 (0.77-1.25) 20.0 µm
0.99 (0.87-1.12)
Test for overall effect: Z = 0.20 (P = 0.84)
1SD lower arteriole-to-venule ratio
The Rotterdam study 20 1.14 (0.98-1.32) 0.06 units
Risk ratio (95% CI)
Test for overall effect: Z = 1.72 (P = 0.08)
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permeability to leucocytes, initiated by rolling and endothe-
lial adhesion,8 and their soluble forms are thought to reflect 
the concentration of membrane-bound adhesion molecules 
on the endothelium.42 In addition, vWF is thought to increase 
prothrombotic and procoagulant activity.8 These markers are 
synthesized by endothelial cells,8 and the microvascular endo-
thelium, with its large surface area and production capacity 
(ie, the microvasculature covers 98% of the total vascular 
surface area),43 is likely to be the most important determinant 
of these plasma concentrations.8 In addition, according to a 
previously described concept, endothelial dysfunction in large 
arteries is paralleled by endothelial dysfunction in resistance 
vessels that contributes to the development of T2DM.44 For 
these reasons, it is plausible that higher circulating concentra-
tions of these markers reflect microvascular endothelial dys-
function. Second, acetylcholine is an endothelium-dependent 
vasodilator because of the release of NO and the production of 
prostaglandins and endothelium-derived hyperpolarizing fac-
tor.45 Consequently, a lower response in the peripheral micro-
vasculature after stimulation with acetylcholine suggests a 
defect in the release of NO, endothelium-derived hyperpolar-
izing factor or prostaglandins, and thus impaired endothelium-
dependent vasodilatation. Third, retinal venular dilation and 
retinal arteriolar narrowing have been associated with endo-
thelial dysfunction.46,47 Hence, both alterations may represent 
a directly microvascular phenotype of endothelial dysfunc-
tion.48 In addition, it has been hypothesized that higher intralu-
minal retinal venular diameters reflect a disrupted endothelial 
surface layer and thereby increase leukocyte adhesion.11 This 
assumption is in line with our meta-analysis, which suggests 
an association between higher venular diameters and incident 
IFG. However, because of the use of static fundus photos it 
is uncertain whether retinal diameters reflect structural or 
functional microvascular changes. Fourth, microalbuminuria 
is considered to reflect various aspects of endothelial dysfunc-
tion in many vascular beds.8 This concept is derived from data 
showing that microalbuminuria is associated with a greater 
transcapillary escape rate of albumin, that is, with greater 
microvascular permeability8 and from data showing that 
microalbuminuria is strongly associated with risk of cardio-
vascular disease, that this association cannot be explained by 
conventional risk factors, and that changes in microalbumin-
uria are paralleled by changes in cardiovascular risk (reviewed 
elsewhere).49
Strengths of our study include its systematic approach and 
the evaluation of population-based studies. To identify all stud-
ies that assessed the association of microvascular dysfunction 
with both T2DM and IFG, we extensively searched Medline 
and Embase. Given the fact that we searched for relatively 
large population-based studies, it seems unlikely that these 
studies will have been published and not identified by our 
search. Therefore, it is likely that we retrieved all published 
data. All studies included in this systematic review adjusted 
for multiple confounders, which makes it unlikely that resid-
ual confounding may have influenced the results, although we 
cannot completely exclude this. In contrast, overcorrection 
may have occurred, as microvascular dysfunction may link 
central obesity, low physical activity, and chronic, low-grade 
inflammation to insulin resistance, and be an intermediate step 
in the pathophysiologic process.3 Adjustment for these factors 
could therefore result in an underestimation of the actual asso-
ciation. In fact, some studies17,37,38 specifically adjusted for 
BMI and were able to quantify the exact influence of adjust-
ing for BMI or waist-to-hip ratio (Table II in the online-only 
Data Supplement). Interestingly, the significant associations 
among sICAM-1,37,38 vWF,17 and sE-selectin37,38 with incident 
T2DM decreased after adjustment for BMI or waist-to-hip 
ratio. Because adjustment for BMI or waist-to-hip ratio may 
be an over adjustment, we conclude that the reported risks 
possibly underestimate the true risk for incident T2DM asso-
ciated with microvascular dysfunction. Another important 
issue to address is whether the association is different among 
different subgroups (ie, whether there is effect modification). 
Three studies included in this systematic review demonstrated 
significant associations between microvascular dysfunc-
tion with incident T2DM in the general population group as 
well as obese,31 inflammation,32 and hypertensive30 popula-
tion groups. In addition, at every level of increasing BMI,31 
C-reactive protein,32 and blood pressure30 there was a stepwise 
increase in the association of markers of microvascular dys-
function with incident T2DM. Taken together, these studies 
suggest that there are significant associations between micro-
vascular dysfunction and incident T2DM in all populations 
groups, with stronger associations in the obese, inflammation, 
and hypertensive groups. However, other studies included in 
this review did not investigate effect modification. Therefore, 
we cannot definitively conclude that the association is stron-
ger in obese or hypertensive individuals, or at higher levels of 
inflammation.
The studies included in this review had several limitations. 
First, because most studies examined mainly white individuals 
(Table 1), the results of our meta-analysis are not necessarily 
valid for other ethnicities. For instance, the Longitudinal Health 
Study36 examined very obese Pima indians, who had higher 
sE-selectin levels as compared with other studies,31,32,34,37,38 
and found no significant associations between plasma markers 
of endothelial dysfunction and T2DM. The authors concluded 
that the substantially higher plasma levels might reduce the 
power to detect an effect of such markers.36 However, ethnic 
differences (eg, different population risks) may also explain 
the variations in T2DM risk. However, the Women’s Health 
Initiative Observational Study32 showed no major differences 
between ethnic groups with respect to plasma markers of 
endothelial dysfunction. In addition, the Monitoring of Trends 
and Determinants in Cardiovascular Disease and Cooperative 
Research in the Region of Augsberg studies38 demonstrated 
no clear differences between men and women (Table 2 and 
Table I in the online-only Data Supplement). Second, power 
problems could explain the lack of significant results in some 
studies. Mykkänen et al23 examined 92 incident T2DM cases 
and demonstrated a positive but nonsignificant relationship 
between microalbuminuria and incident T2DM, which sug-
gests a lack of power. In contrast, other studies that did dem-
onstrate significant associations,16,19,27,33 included between 117 
and 391 cases of incident T2DM (Table 1). Third, different 
methods for the assessment of microalbuminuria were used. 
The Prevention of Renal and Vascular End Stage Disease 
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24-hour urine collections (the accepted standard), whereas 
other studies18,19,23,27,33 used less precise morning urine sam-
ples. Although morning urine samples are a good screening 
test for albuminuria,50 its lesser precision may have resulted in 
less strong associations with wider CI.
Our meta-analysis had some additional limitations. First, 
the concept that high plasma levels of endothelial dysfunction 
reflect endothelial dysfunction requires that endothelial cells 
are the major source of the plasma markers and that higher 
plasma levels are caused more by increased synthesis than 
by decreased clearance.8,41 Indeed, sE-selectin is exclusively 
synthesized by endothelial cells,51 which may explain the 
strong association between sE-selectin and incident T2DM. 
In addition, in T2DM, higher plasma vWF levels are deter-
mined by synthesis rather than clearance.52 However, sICAM-
1, sVCAM-1, and vWF are expressed by several other cell 
types.51 Furthermore, except for vWF there is no information 
on the clearance of these markers. Consequently, the valid-
ity of these assumptions remains uncertain.8,41 Second, we 
acknowledge the limited availability of prospective stud-
ies that could be included in analyses of single estimates of 
microvascular dysfunction. Because of this low number we 
could not formally test for heterogeneity,53 and we could not 
perform meta-regression analyses. As a consequence, we can-
not exclude statistical heterogeneity, although all CIs over-
lapped (Figures 2 and 3). Third, microvascular function is 
strongly tissue-dependent.54 In this systematic overview, we 
searched for all available prospective population-based stud-
ies that focused on any marker of microvascular function. 
Probably because of the difficulties of microvascular mea-
surements in population-based studies, we only found stud-
ies investigating the microcirculation in skin, eye, and kidney. 
On the one hand, this could limit the generalizability of the 
data, because the association of microvascular dysfunction 
and incident T2DM may be tissue-specific (eg, be limited 
to skeletal muscle microcirculation). On the other hand, the 
meta-analysis in fact demonstrated that all markers of micro-
vascular dysfunction (skin, eye, as well as kidney) are associ-
ated with incident T2DM. This suggests that microvascular 
function in quite different tissues does have common proper-
ties, a notion supported by other data. For example, it has been 
demonstrated that skeletal muscle microvascular dysfunction 
was associated with brain microvascular damage among indi-
viduals with hypertension.55
This systematic review underscores the importance of 
microvascular dysfunction in the pathogenesis of T2DM. 
However, this systematic review cannot prove any causal rela-
tionship. Therefore, more studies are needed to investigate 
this. These findings may contribute to more precise assess-
ment of risk of T2DM. In addition, unraveling how micro-
vascular dysfunction is determined and how it leads to T2DM 
may lead to new treatment targets as well as to a better under-
standing of why certain existing treatments are associated 
with decreased risk of developing T2DM (ie, angiotensin con-
verting enzyme inhibitors, angiotensin receptor blockers, and 
physical activity).
In conclusion, we demonstrated that microvascular dys-
function, assessed by use of different methods, was associated 
with incident T2DM and even IFG. Our findings are consis-
tent with the hypothesis that microvascular dysfunction is 
causally linked with T2DM.
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